Q3 2013
Released Nov 12, 2013, after the close
10-Q filed Nov 13, 2013, 44 days after period end · 0001193125-13-438833
Q3 2013 · 10-Q
Revenue$0.00$0.00 — vs Q3 2012no prior Q2 2013 on file
Net Income-$3.48M-$3.48M N/M vs Q3 2012N/M vs Q2 2013
EPS Diluted-$0.39-$0.39 N/M vs Q3 2012N/M vs Q2 2013
Operating Income-$3,545,765N/M
Operating Cash Flowderived-$4,474,821—
Free Cash Flowderived-$4,474,821—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$3.48M | -$1.01M | $0.00 |
| EPS Diluted | -$0.39 | -$0.23 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR